By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 79.46 |
Change Today | -0.77 |
% Change | -0.96 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 399,797 |
Shares Issued | 1,256.00m |
Market Cap | 99,800m |
Beta | 0.76 |
Strong Buy | 14 |
Buy | 8 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 1 |
Total | 27 |
Time | Volume / Share Price |
15:49 | 1 @ 79.46 |
15:49 | 76 @ 79.46 |
15:49 | 39 @ 79.46 |
15:49 | 86 @ 79.46 |
15:49 | 49 @ 79.46 |
You are here: research